Campbell Murray

Campbell Murray is a Director at Cerevance and has held notable leadership roles at multiple organizations, including serving as Managing Director of Novartis Venture Fund from 2005 to 2020. Currently, they co-founded and serve as Managing Partner at Double Point Ventures, and they occupy several directorships at companies such as Synchron and Umoja Biopharma. Campbell's robust educational background includes a Bachelor's in Human Biology and a Bachelor of Medicine from the University of Auckland, as well as a Master's in Public Policy from the Kennedy School and an MBA from Harvard Business School.